Abstract
Erythromycin resistance rates were found to be increased, from 7.1 in 1993 to 32.8% in 1997, among community-acquired Streptococcus pneumoniae isolates from the Siena area of central Italy. Most of the erythromycin-resistant isolates carried ermAM determinants and were also resistant to josamycin and clindamycin, whereas a minority (5.8%) carried mefA determinants and remained susceptible to the latter drugs.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Community-Acquired Infections
-
Drug Resistance, Microbial / physiology
-
Erythromycin / pharmacology*
-
Humans
-
Italy
-
Microbial Sensitivity Tests
-
Pneumonia, Pneumococcal / microbiology
-
Streptococcus pneumoniae / drug effects*
-
Streptococcus pneumoniae / physiology
Substances
-
Anti-Bacterial Agents
-
Erythromycin